Allyl chloride

CASRN 107-05-1

  • IRIS Summary (PDF) (13 pp, 139 K)
  • Status: Allyl chloride is not being reassessed by IRIS at this time.

Health Hazard Assessments for Effects Other than Cancer


Reference Dose for Oral Exposure (RfD) (PDF) (13 pp, 139 K)
Not assessed under the IRIS Program.

Reference Concentration for Inhalation Exposure (RfC) (PDF) (13 pp, 139 K) last updated: 12/01/1991

RfC (mg/m3) System Basis PoD Composite UF Confidence
1 x10-3 Nervous Functional and histological peripheral neurotoxicity NOAEL (HEC): 3.6
mg/m3
3000 Low

Cancer Assessment


Weight of Evidence for Cancer (PDF) (13 pp, 139 K) last updated: 09/01/1990

WOE Characterization Framework for WOE Characterization
C (Possible human carcinogen) Guidelines for Carcinogen Risk Assessment (US EPA, 1986)
Basis:
  • Classification is based on a low (but biologically important) incidence of forestomach tumors in female mice and positive results in a variety of genetic toxicity tests. Allyl chloride is an alkylating agent and structurally related to probable human carcinogens.
  • This may be a synopsis of the full weight-of-evidence narrative.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (13 pp, 139 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (13 pp, 139 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.